BG104692A - Extended release tiagabine formulation - Google Patents

Extended release tiagabine formulation

Info

Publication number: BG104692A
Authority: BG; Bulgaria
Prior art keywords: extended release; formulation; release tiagabine; tiagabine; administered
Prior art date: 1998-01-22

Application number

BG104692A

Other languages

Bulgarian (bg)

English (en)

Inventor

Francisco Alvarez

Russell SLADE

Kathleen APFELBAUM

David Brown

Linda Gustavson

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-22

Filing date

2000-08-15

Publication date

2001-05-31

2000-08-15 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

2001-05-31 Publication of BG104692A publication Critical patent/BG104692A/xx

Links

238000013265 extended release Methods 0.000 title abstract 2
238000009472 formulation Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
PBJUNZJWGZTSKL-MRXNPFEDSA-N tiagabine Chemical compound C1=CSC(C(=CCCN2C[C@@H](CCC2)C(O)=O)C2=C(C=CS2)C)=C1C PBJUNZJWGZTSKL-MRXNPFEDSA-N 0.000 title abstract 2
229960001918 tiagabine Drugs 0.000 title abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BG104692A 1998-01-22 2000-08-15 Extended release tiagabine formulation BG104692A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7213098P	1998-01-22	1998-01-22
PCT/US1999/001242 WO1999037302A1 (en)	1998-01-22	1999-01-22	Extended release tiagabine formulations with reduced side-effects

Publications (1)

Publication Number	Publication Date
BG104692A true BG104692A (en)	2001-05-31

Family

ID=22105780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104692A BG104692A (en)	1998-01-22	2000-08-15	Extended release tiagabine formulation

Country Status (23)

Country	Link
US (1)	US20070053980A1 (de)
EP (1)	EP1049470B1 (de)
JP (1)	JP2002501022A (de)
KR (1)	KR20010034313A (de)
CN (1)	CN1145484C (de)
AR (1)	AR018041A1 (de)
AT (1)	ATE350035T1 (de)
AU (1)	AU2239599A (de)
BG (1)	BG104692A (de)
CA (1)	CA2318448A1 (de)
CO (1)	CO4970814A1 (de)
DE (1)	DE69934670D1 (de)
HU (1)	HUP0101739A3 (de)
IL (1)	IL137324A0 (de)
NO (1)	NO20003677L (de)
NZ (1)	NZ505725A (de)
PL (1)	PL194595B1 (de)
SA (1)	SA99200204B1 (de)
SK (1)	SK11072000A3 (de)
TR (2)	TR200505223T2 (de)
TW (1)	TW585787B (de)
WO (1)	WO1999037302A1 (de)
ZA (1)	ZA99407B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6872734B2 (en)	2000-10-20	2005-03-29	Abbott Laboratories	Use of tiagabine for treatment of diabetic neuropathy and migraine
KR100510270B1 (ko) *	2002-11-29	2005-08-26	센츄론(주)	펠렛타이저를 이용한 서방성 제제의 제조방법
CN102908327B (zh) *	2011-08-05	2015-03-11	江苏恒瑞医药股份有限公司	伊伐布雷定或其可药用盐的缓释制剂
KR102051132B1 (ko) *	2017-03-17	2019-12-02	주식회사 종근당	미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5009897A (en) *	1988-06-24	1991-04-23	Abbott Laboratories	Pharmaceutical granules and tablets made therefrom
US5126145A (en) *	1989-04-13	1992-06-30	Upsher Smith Laboratories Inc	Controlled release tablet containing water soluble medicament
US5273758A (en) *	1991-03-18	1993-12-28	Sandoz Ltd.	Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
WO1995005808A1 (en) *	1993-08-24	1995-03-02	Abbott Laboratories	Oil-based tableting method
US5430021A (en) *	1994-03-18	1995-07-04	Pharmavene, Inc.	Hydrophobic drug delivery systems
ZA953078B (en) *	1994-04-28	1996-01-05	Alza Corp	Effective therapy for epilepsies
CZ292256B6 (cs) *	1995-05-05	2003-08-13	Novo Nordisk A/S	Farmaceutická směs a způsob její přípravy
US5783212A (en) *	1996-02-02	1998-07-21	Temple University--of the Commonwealth System of Higher Education	Controlled release drug delivery system
ATE212550T1 (de) *	1997-08-01	2002-02-15	Elan Corp Plc	Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
US5843477A (en) *	1997-09-30	1998-12-01	Bayer Corporation	Lubricants for use in tabletting

1999
- 1999-01-20 ZA ZA9900407A patent/ZA99407B/xx unknown
- 1999-01-21 CO CO99003109A patent/CO4970814A1/es unknown
- 1999-01-22 AT AT99902409T patent/ATE350035T1/de not_active IP Right Cessation
- 1999-01-22 SK SK1107-2000A patent/SK11072000A3/sk unknown
- 1999-01-22 EP EP99902409A patent/EP1049470B1/de not_active Expired - Lifetime
- 1999-01-22 CA CA002318448A patent/CA2318448A1/en not_active Abandoned
- 1999-01-22 AU AU22395/99A patent/AU2239599A/en not_active Abandoned
- 1999-01-22 JP JP2000528284A patent/JP2002501022A/ja not_active Withdrawn
- 1999-01-22 CN CNB998040886A patent/CN1145484C/zh not_active Expired - Fee Related
- 1999-01-22 DE DE69934670T patent/DE69934670D1/de not_active Expired - Lifetime
- 1999-01-22 WO PCT/US1999/001242 patent/WO1999037302A1/en not_active Ceased
- 1999-01-22 HU HU0101739A patent/HUP0101739A3/hu unknown
- 1999-01-22 KR KR1020007008031A patent/KR20010034313A/ko not_active Ceased
- 1999-01-22 PL PL99342767A patent/PL194595B1/pl unknown
- 1999-01-22 NZ NZ505725A patent/NZ505725A/xx unknown
- 1999-01-22 TR TR2005/05223T patent/TR200505223T2/xx unknown
- 1999-01-22 AR ARP990100254A patent/AR018041A1/es unknown
- 1999-01-22 TR TR2000/02102T patent/TR200002102T2/xx unknown
- 1999-01-22 IL IL13732499A patent/IL137324A0/xx unknown
- 1999-03-16 TW TW088100990A patent/TW585787B/zh not_active IP Right Cessation
- 1999-06-01 SA SA99200204A patent/SA99200204B1/ar unknown
2000
- 2000-07-18 NO NO20003677A patent/NO20003677L/no not_active Application Discontinuation
- 2000-08-15 BG BG104692A patent/BG104692A/xx unknown
2006
- 2006-11-03 US US11/592,694 patent/US20070053980A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999037302A1 (en)	1999-07-29
CO4970814A1 (es)	2000-11-07
DE69934670D1 (de)	2007-02-15
PL342767A1 (en)	2001-07-02
CN1145484C (zh)	2004-04-14
NO20003677D0 (no)	2000-07-18
KR20010034313A (ko)	2001-04-25
HUP0101739A2 (hu)	2002-03-28
EP1049470B1 (de)	2007-01-03
SK11072000A3 (sk)	2001-01-18
NZ505725A (en)	2003-01-31
ZA99407B (en)	1999-07-20
TR200505223T2 (tr)	2006-04-21
ATE350035T1 (de)	2007-01-15
HUP0101739A3 (en)	2002-10-28
AR018041A1 (es)	2001-10-31
SA99200204B1 (ar)	2006-10-11
AU2239599A (en)	1999-08-09
IL137324A0 (en)	2001-07-24
NO20003677L (no)	2000-09-20
TR200002102T2 (tr)	2000-12-21
CA2318448A1 (en)	1999-07-29
JP2002501022A (ja)	2002-01-15
US20070053980A1 (en)	2007-03-08
EP1049470A1 (de)	2000-11-08
TW585787B (en)	2004-05-01
PL194595B1 (pl)	2007-06-29
CN1293571A (zh)	2001-05-02

Publication	Publication Date	Title
ZA200007715B (en)	2001-06-20	Stable extended release oral dosage composition.
MY129356A (en)	2007-03-30	Electrospun pharmaceutical compositions
BG105564A (en)	2002-01-31	Galantamine-containing composition with controlled release
ZA200003121B (en)	2001-12-21	Flash-melt oral dose formulations.
ZA200007714B (en)	2001-08-16	Extended release oral dosage composition.
TW355683B (en)	1999-04-11	Composition containing micronized nebivolol
WO2000041681A3 (de)	2000-12-07	ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
MY125921A (en)	2006-08-30	Compositions containing organic compounds
YU22399A (sh)	2003-01-31	Čvrsti farmaceutski sastavi koji obuhvataju ciklosporin i anjonsko površinski-aktivno sredstvo
HUP0202495A3 (en)	2004-05-28	Stable medicinal compositions for oral use
AU3632497A (en)	1998-03-06	Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
IL133397A (en)	2005-07-25	Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
AU2001296865A1 (en)	2002-03-22	(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
PT998287E (pt)	2003-09-30	Utilizacao de levobupivacaina
ZA200007548B (en)	2001-06-19	Matrix table enabling the prolonged release of trimetazidine after administration by the oral route.
HRPK20010706B1 (en)	2004-12-31	Tolperison-containing, pharmaceutical preparation for oral administration
AU9018898A (en)	1999-03-08	Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
ZA200308221B (en)	2004-09-29	Pharmaceutical compositions for oral and topical administration.
MXPA01012478A (es)	2003-10-14	Formulaciones farmaceuticas mejoradas.
AU2001287977A1 (en)	2002-04-02	Controlled release formulations for oral administration
AU2001284444A1 (en)	2002-06-13	Preparations for oral administration
YU19399A (sh)	2001-09-28	Lokalni anestetik za spoljnu upotrebu
HRP20010684B1 (hr)	2011-01-31	Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
AU2001264044A1 (en)	2001-12-11	1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
EP0670166A3 (de)	1996-06-12	Oral verabreichbare Arzneimittel.